Rivus Pharmaceuticals, a biopharma company focused on therapies for cardiometabolic health, announced positive data from a Phase IIa clinical trial.

A made-in-Canada life sciences company, Nimium Therapeutics, launched to develop novel therapies for patients with cardiometabolic diseases.

Pharma giant Amgen became the most recent tenant of the Bay Area’s massive life sciences campus known as Gateway of the Pacific, with a 240,000-square-foot facility.